The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Necroptosis microenvironment directs lineage commitment in liver cancer
Open accessAbstract
Primary liver cancer represents a major health problem. It comprises hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC), which differ markedly with regards to their morphology, metastatic potential and responses to therapy. However, the regulatory molecules and tissue context that commit transformed hepatic cells towards HCC or ICC are largely unknown. Here we show that the hepatic microenvironment epigenetically shapes lineage commitment in mosaic mouse models of liver tumorigenesis. Whereas a necroptosis-associated hepatic cytokine microenvironment determines ICC outgrowth from oncogenically transformed hepatocytes, hepatocytes containing identical oncogenic drivers give rise to HCC if they are surrounded by apoptotic hepatocytes. Epigenome and transcriptome profiling of mouse HCC and ICC singled out Tbx3 and Prdm5 as major microenvironment-dependent and epigenetically regulated lineage-commitment factors, a function that is conserved in humans. Together, our results provide insight into lineage commitment in liver tumorigenesis, and explain molecularly why common liver-damaging risk factors can lead to either HCC or ICC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Indeed, hepatocytes can give rise to both HCC and CCA18, and our data suggest that PROX1 regulates this decision.”
From Active repression of cell fate plasticity by PROX1 safeguards hepatocyte identity and prevents liver tumorigenesis (2025) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trimmomatic: a flexible trimmer for Illumina sequence data
Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849
A framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R. E., Garimella, K. V., Maguire, J., Hartl, C., Philippakis, A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,457
Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y., & Greenleaf, W. J. (2013) · Nature Methods · doi:10.1038/nmeth.2688 · Cited by 6,422
Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt
Durinck, S., Spellman, P. T., Birney, E., & Huber, W. K. (2009) · Nature Protocols · doi:10.1038/nprot.2009.97 · Cited by 4,156
deepTools: a flexible platform for exploring deep-sequencing data
Ramírez, F., Dündar, F., Diehl, S., Grüning, B. A., & Manke, T. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku365 · Cited by 3,738
Research works printed but not linked: 1
- Aronesty, E. Comparison of sequencing utility programs. Open Bioinformatics 7, 1–8 (2013). · DOI
Cited by
Sorted by citations
Llovet, J. M., Kelley, R. K., Villanueva, A., Singal, A. G., Pikarsky, E., Roayaie, S., Lencioni, R., Koike, K., Zucman-Rossi, J., & Finn, R. S. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00240-3 · Cited by 7,055
Cell death: a review of the major forms of apoptosis, necrosis and autophagy
D'Arcy, M. (2019) · Cell Biology International · doi:10.1002/cbin.11137 · Cited by 2,430
The role of necroptosis in cancer biology and therapy
Gong, Y., Fan, Z., Luo, G., Yang, C., Huang, Q., Fan, K., He, C., Jin, K., Ni, Q., Yu, X., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1029-8 · Cited by 1,069
Liver tumour immune microenvironment subtypes and neutrophil heterogeneity
Xue, R., Zhang, Q., Cao, Q., Kong, R., Xiao, X., Liu, H., Feng, M., Wang, F., Cheng, J., Zhao, L., et al. (2022) · Nature · doi:10.1038/s41586-022-05400-x · Cited by 969
Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer
Ma, L., Hernandez, M. O., Zhao, Y., Mehta, M., Tran, B. Q., Kelly, M. C., Rae, Z., Hernandez, J. M., Davis, J. L., Martin, S. P., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.08.007 · Cited by 856
Self-citationTumour evolution in hepatocellular carcinoma
Craig, A. J., von Felden, J., García‐Lezana, T., Sarcognato, S., & Villanueva, A. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0229-4 · Cited by 842
Targeting ROS in cancer: rationale and strategies
Glorieux, C., Liu, S., Trachootham, D., & Huang, P. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-00979-4 · Cited by 714
The immunological and metabolic landscape in primary and metastatic liver cancer
Li, X., Ramadori, P., Pfister, D. R., Seehawer, M., Zender, L., & Heikenwälder, M. F. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00383-9 · Cited by 639
Self-citationNecroptosis and tumor progression
Yan, J., Wan, P., Choksi, S., & Liu, Z.-G. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.09.003 · Cited by 457
The Apoptosis Paradox in Cancer
Morana, O., Wood, W., & Gregory, C. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031328 · Cited by 442
Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations
Affo, S., Nair, A., Brundu, F., Ravichandra, A., Bhattacharjee, S., Matsuda, M., Chin, L., Filliol, A., Wen, W., Song, X., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.03.012 · Cited by 416
Self-citationTumor initiation and early tumorigenesis: molecular mechanisms and interventional targets
Zhang, S., Xiao, X., Yi, Y., Wang, X., Zhu, L., Shen, Y., Lin, D., & Wu, C. H. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01848-7 · Cited by 451
Self-citationATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis
He, F., Zhang, P., Liu, J., Wang, R., Kaufman, R. J., Yaden, B. C., & Karin, M. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.016 · Cited by 408
Modes of Regulated Cell Death in Cancer
Koren, E., & Fuchs, Y. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0789 · Cited by 384
Cell Death in the Origin and Treatment of Cancer
Strasser, A., & Vaux, D. L. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.05.014 · Cited by 377
Gut Microbiome Directs Hepatocytes to Recruit MDSCs and Promote Cholangiocarcinoma
Zhang, Q., Ma, C., Duan, Y., Heinrich, B., Rosato, U., Diggs, L. P., Ma, L., Roy, S., Fu, Q., Brown, Z. J., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0304 · Cited by 266
Self-citationMichels, B. E., Mosa, M. H., Streibl, B. I., Zhan, T., Menche, C., Abou-El-Ardat, K., Darvishi, T., Członka, E., Wagner, S., Winter, J., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.04.003 · Cited by 222
Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice
Moya, I. M., Castaldo, S. A., den Mooter, L. V., Soheily, S., Sansores-García, L., Jacobs, J., Mannaerts, I., Xie, J., Verboven, E., Hillen, H., et al. (2019) · Science · doi:10.1126/science.aaw9886 · Cited by 214
Self-citationCombined locoregional-immunotherapy for liver cancer
Greten, T. F., Mauda‐Havakuk, M., Heinrich, B., Korangy, F., & Wood, B. J. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.01.027 · Cited by 211
Carcinogenesis: Failure of resolution of inflammation?
Fishbein, A., Hammock, B. D., Serhan, C. N., & Panigrahy, D. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107670 · Cited by 213
Gut epithelial TSC1/mTOR controls RIPK3-dependent necroptosis in intestinal inflammation and cancer
Xie, Y., Zhao, Y., Shi, L., Li, W., Chen, K., Li, M., Chen, X., Zhang, H., Li, T., Matsuzawa, Y., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci133264 · Cited by 202
Hou, J., Zhang, H., Sun, B., & Karin, M. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.014 · Cited by 197
Necroptosis, tumor necrosis and tumorigenesis
Liu, Z.-G., & Jiao, D. (2020) · Cell Stress · doi:10.15698/cst2020.01.208 · Cited by 194
Yang, Y., Wu, M., Cao, D., Yang, C., Jin, J., Wu, L., Hong, X., Li, W., Lu, L., Li, J., et al. (2021) · Science Advances · doi:10.1126/sciadv.abf6290 · Cited by 187
Self-citationThe pathological features of regulated necrosis
Tonnus, W., Meyer, C., Paliege, A., Belavgeni, A., von Mäßenhausen, A., Bornstein, S. R., Hugo, C., Becker, J. U., & Linkermann, A. (2019) · The Journal of Pathology · doi:10.1002/path.5248 · Cited by 168
DefED-Net: Deformable Encoder-Decoder Network for Liver and Liver Tumor Segmentation
Lei, T., Wang, R., Zhang, Y., Wan, Y., Liu, C., & Nandi, A. K. (2021) · IEEE Transactions on Radiation and Plasma Medical Sciences · doi:10.1109/trpms.2021.3059780 · Cited by 155
The potential role of necroptosis in inflammaging and aging
Royce, G. H., Brown‐Borg, H. M., & Deepa, S. S. (2019) · GeroScience · doi:10.1007/s11357-019-00131-w · Cited by 137
Hepatocellular Carcinoma in 2021: An Exhaustive Update
Philips, C., Rajesh, S., Nair, D. C., Ahamed, R., Abduljaleel, J. K., & Augustine, P. (2021) · Cureus · doi:10.7759/cureus.19274 · Cited by 130
Yap-Sox9 signaling determines hepatocyte plasticity and lineage-specific hepatocarcinogenesis
Liu, Y., Zhuo, S., Zhou, Y., Ma, L., Sun, Z., Wu, X., Wang, X. W., Gao, B., & Yang, Y. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.11.010 · Cited by 129
Self-citationThe role of necroptosis in cancer: A double-edged sword?
Qin, X., Ma, D., Tan, Y., Wang, H., & Cai, Z. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.01.006 · Cited by 131
Cellular Interactions in the Tumor Microenvironment: The Role of Secretome
da Cunha, B. R., Domingos, C., Stefanini, A. C. B., Henrique, T., Polachini, G. M., Castelo‐Branco, P., & Tajara, E. H. (2019) · Journal of Cancer · doi:10.7150/jca.21780 · Cited by 133
Laser-assisted 3D bioprinting of exocrine pancreas spheroid models for cancer initiation study
Hakobyan, D., Medina, C. F., Dusserre, N., Stachowicz, M., Handschin, C., Fricain, J., Guillermet‐Guibert, J., & Oliveira, H. (2020) · Biofabrication · doi:10.1088/1758-5090/ab7cb8 · Cited by 129
Joseph, N. M., Tsokos, C. G., Umetsu, S. E., Shain, A. H., Kelley, R. K., Onodera, C. S., Bowman, S., Talevich, E., Ferrell, L. D., Kakar, S., et al. (2019) · The Journal of Pathology · doi:10.1002/path.5243 · Cited by 126
Immune microenvironment in hepatocellular carcinoma: from pathogenesis to immunotherapy
Seyhan, D., Allaire, M., Fu, Y., Conti, F., Wang, X. W., Gao, B., & Lafdil, F. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01308-4 · Cited by 138
Self-citationCholangiocarcinoma: a guide for the nonspecialist
Alsaleh, M., Leftley, Z., Barbera, T. A., Sithithaworn, P., Khuntikeo, N., Loilome, W., Yongvanit, P., Cox, I. J., Chamodol, N., Syms, R. R. A., et al. (2018) · International Journal of General Medicine · doi:10.2147/ijgm.s186854 · Cited by 119
Zhou, T., Li, S., Xiang, D., Liu, J., Sun, W. C., Cui, X., Ning, B., Li, X., Cheng, Z., Jiang, W., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00299-0 · Cited by 118
Paraptosis: a unique cell death mode for targeting cancer
Hanson, S., Dharan, A., Jinsha, P. V., Pal, S., Nair, B. G., Kar, R., & Mishra, N. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1159409 · Cited by 121
Multitasking Kinase RIPK1 Regulates Cell Death and InflammationPreprint
Newton, K. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a036368 · Cited by 107
Oncogenic driver genes and tumor microenvironment determine the type of liver cancer
Wang, G., Wang, Q., Liang, N. N., Xue, H., Yang, T., Chen, X., Qiu, Z., Zeng, C., Sun, T., Yuan, W., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2509-x · Cited by 108
Role of Oxidative Stress in Liver Disorders
Conde de la Rosa, L., Goicoechea, L., Torres, S., Garcia-Ruiz, C., & Fernandez-Checa, J. C. (2022) · Livers · doi:10.3390/livers2040023 · Cited by 107
CD73 promotes tumor metastasis by modulating RICS/RhoA signaling and EMT in gastric cancer
Xu, Z., Gu, C.-C., Yao, X., Guo, W., Wang, H., Tian, L., Li, F., Chen, D., Wu, J., Ye, G., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2403-6 · Cited by 105
Jiang, K., Dong, C., Yin, Z., Li, R., Mao, J., Wang, C., Zhang, J., Gao, Z., Liang, R., Wang, Q., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03179-1 · Cited by 107
Afonso, M. B., Rodrigues, P. M., Mateus‐Pinheiro, M., Simão, A. L., Gaspar, M. M., Majdi, A., Arretxe, E., Alonso, C., Santos‐Laso, Á., Jiménez-Agüero, R., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-321767 · Cited by 103
Cholangiocarcinoma 2026: status quo, unmet needs and priorities
Bañales, J. M., Rodrigues, P. M., Affò, S., Andersen, J. B., Aspichueta, P., Boulter, L., Bridgewater, J. A., Calvisi, D. F., Cárdenas, A., Cardinale, V., et al. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01153-w · Cited by 112
Self-citationNanomedicines inhibiting tumor metastasis and recurrence and their clinical applications
Kong, X., Cheng, R., Wang, J., Fang, Y., & Hwang, K. C. (2020) · Nano Today · doi:10.1016/j.nantod.2020.101004 · Cited by 93
Necroptosis pathways in tumorigenesis
Zhang, T., Wang, Y., Inuzuka, H., & Wei, W. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.07.007 · Cited by 97
RIP Kinases in Liver Cell Death, Inflammation and Cancer
Kondylis, V., & Pasparakis, M. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.10.007 · Cited by 85
Liver Inflammation and Hepatobiliary Cancers
Leone, V., Ali, A., Weber, A., Tschaharganeh, D. F., & Heikenwälder, M. F. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.01.012 · Cited by 87
Self-citationComplex roles of necroptosis in cancer
Zhu, F., Zhang, W., Yang, T., & He, S. (2019) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1900160 · Cited by 81
Untangling the web of intratumour heterogeneity
Li, Z., Seehawer, M., & Polyák, K. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00969-x · Cited by 82
Self-citationCariani, E., & Missale, G. (2019) · Liver International · doi:10.1111/liv.14192 · Cited by 83
The structure of a minimum amyloid fibril core formed by necroptosis-mediating RHIM of human RIPK3
Wu, X., Ma, Y., Zhao, K., Zhang, J., Sun, Y., Li, Y., Dong, X.-Q., Hu, H., Liu, J., Wang, J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2022933118 · Cited by 81
NAD+ salvage governs mitochondrial metabolism, invigorating natural killer cell antitumor immunity
Guo, X., Tan, S., Wang, T., Sun, R., Li, S., Tian, P., Li, M., Wang, Y., Zhang, Y., Yan, Y., et al. (2022) · Hepatology · doi:10.1002/hep.32658 · Cited by 81
Cell of origin in biliary tract cancers and clinical implications
Moeini, A., Haber, P. K., & Sia, D. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100226 · Cited by 85
Shi, S., Wang, X., van der Laan, L. J. W., Pan, Q., & Verstegen, M. M. A. (2021) · Transplantation · doi:10.1097/tp.0000000000003691 · Cited by 84
Self-citationFouassier, L., Marzioni, M., Afonso, M. B., Dooley, S., Gaston, K., Giannelli, G., Rodrigues, C. M. P., Lozano, E., Mancarella, S., Segatto, O., et al. (2019) · Liver International · doi:10.1111/liv.14102 · Cited by 79
Aizawa, S., Brar, G., & Tsukamoto, H. (2019) · Gut and Liver · doi:10.5009/gnl18486 · Cited by 80
Sun, J., Esplugues, E., Bort, A., Cardelo, M. P., Ruz‐Maldonado, I., Fernández‐Tussy, P., Wong, C., Wang, H., Ojima, I., Kaczocha, M., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01019-6 · Cited by 79
Liu, X., Lu, Y., & Qin, S. (2021) · Future Oncology · doi:10.2217/fon-2020-1290 · Cited by 76
Fishbein, A., Wang, W., Yang, H., Yang, J., Hallisey, V. M., Deng, J., Verheul, S. M. L., Hwang, S. H., Gartung, A., Wang, Y., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2007412117 · Cited by 80
Cristinziano, G., Porru, M., Lamberti, D., Buglioni, S., Rollo, F., Amoreo, C. A., Manni, I., Giannarelli, D., Cristofoletti, C., Russo, G., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.02.032 · Cited by 79
Quantitative and Dynamic Catalogs of Proteins Released during Apoptotic and Necroptotic Cell Death
Tanzer, M. C., Frauenstein, A., Stafford, C. A., Phulphagar, K. M., Mann, M., & Meissner, F. (2020) · Cell Reports · doi:10.1016/j.celrep.2019.12.079 · Cited by 79
Xie, J., Liang, C., Tang, Q., Wei, W., Cao, Y., Wu, C., Hang, J., Zhang, K., Shi, J., & Wang, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.847624 · Cited by 73
Multifaceted Role of PRDM Proteins in Human Cancer
Casamassimi, A., Rienzo, M., Zazzo, E. D., Sorrentino, A., Fiore, D., Proto, M., Moncharmont, B., Gazzerro, P., Bifulco, M., & Abbondanza, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072648 · Cited by 76
Mediators of necroptosis: from cell death to metabolic regulation
Wu, X., Nagy, L. E., & Gautheron, J. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-023-00011-z · Cited by 77
Mitochondrial Mechanisms of Necroptosis in Liver Diseases
Xue, C., Gu, X., Li, G., Bao, Z., & Li, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010066 · Cited by 70
RIPK3 signaling and its role in the pathogenesis of cancers
Liu, S., Joshi, K., Denning, M. F., & Zhang, J. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03947-y · Cited by 71
The Fire within: Cell-Autonomous Mechanisms in Inflammation-Driven Cancer
Todoric, J., & Karin, M. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.04.001 · Cited by 69
The gut–liver axis: host microbiota interactions shape hepatocarcinogenesis
Silveira, M. A. D., Bilodeau, S., Greten, T. F., Wang, X. W., & Trinchieri, G. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.02.009 · Cited by 67
Self-citationDrug delivery strategy in hepatocellular carcinoma therapy
Yang, S., Cai, C., Wang, H., Ma, X., Shao, A., Sheng, J., & Yu, C. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-021-00796-x · Cited by 66
Tian, P., Yang, W., Guo, X., Wang, T., Tan, S., Sun, R., Xiao, R., Wang, Y., Jiao, D., Xu, Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37419-7 · Cited by 70
Lee, Y., Wang, J. J., Luu, M., Noureddin, M., Nissen, N. N., Patel, T. C., Roberts, L. R., Singal, A. G., Gores, G. J., & Yang, J. D. (2021) · Hepatology · doi:10.1002/hep.32007 · Cited by 65
FGFR2 Inhibition in Cholangiocarcinoma
Vogel, A., Segatto, O., Stenzinger, A., & Saborowski, A. L. (2022) · Annual Review of Medicine · doi:10.1146/annurev-med-042921-024707 · Cited by 63
Types of Cell Death from a Molecular Perspective
Hajibabaie, F., Abedpoor, N., & Mohamadynejad, P. (2023) · Biology · doi:10.3390/biology12111426 · Cited by 69
Human liver organoids: From generation to applications
Afonso, M. B., Marques, V., van Mil, S. W. C., & Rodrigues, C. M. P. (2024) · Hepatology · doi:10.1097/hep.0000000000000343 · Cited by 61
LXRα activation and Raf inhibition trigger lethal lipotoxicity in liver cancer
Rudalska, R., Harbig, J., Snaebjornsson, M. T., Klotz, S., Zwirner, S., Taranets, L., Heinzmann, F., Kronenberger, T., Förster, M., Cui, W., et al. (2021) · Nature Cancer · doi:10.1038/s43018-020-00168-3 · Cited by 59
Self-citationCurrent and novel therapeutic opportunities for systemic therapy in biliary cancer
Marı́n, J. J. G., Prete, M. G., Lamarca, Á., Tavolari, S., Landa-Magdalena, A., Brandi, G., Segatto, O., Vogel, A., Macı́as, R. I. R., Rodrigues, P. M., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0987-3 · Cited by 58
Mechanism of cancer stemness maintenance in human liver cancer
Liang, N. N., Yang, T., Huang, Q., Yu, P., Liu, C., Chen, L., Wang, Q., Wang, G., & He, X. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04848-z · Cited by 60
Verboom, L., Martens, A., Priem, D., Hoste, E., Sze, M., Vikkula, H., Hove, L. V., Voet, S., Roels, J., Maelfait, J., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.028 · Cited by 57
Sirica, A. E., Strazzabosco, M., & Cadamuro, M. (2020) · Advances in cancer research · doi:10.1016/bs.acr.2020.10.005 · Cited by 59
Leibold, J., Ruscetti, M. A., Cao, Z., Ho, Y.-J., Baslan, T., Zou, M., Abida, W. M., Feucht, J., Han, T., Barriga, F. M., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1242 · Cited by 54
Liang, B., Zhou, Y., Qian, M., Xu, M., Wang, J., Zhang, Y., Song, X., Wang, H., Lin, S., Ren, C., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.01.044 · Cited by 55
Liver cancer heterogeneity modeled by in situ genome editing of hepatocytes
Tang, M., Zhao, Y., Zhao, J., Wei, S., Liu, M., Zheng, N., Geng, D., Han, S., Zhang, Y., Zhong, G., et al. (2022) · Science Advances · doi:10.1126/sciadv.abn5683 · Cited by 54
RIPK3 dampens mitochondrial bioenergetics and lipid droplet dynamics in metabolic liver disease
Afonso, M. B., Islam, T., Magusto, J., Amorim, R., Lenoir, V., Simões, R. F., Teixeira, J., Silva, L. C., Wendum, D., Jéru, I., et al. (2022) · Hepatology · doi:10.1002/hep.32756 · Cited by 56
Dark Side of Cytotoxic Therapy: Chemoradiation-Induced Cell Death and Tumor Repopulation
Jiang, M., Gu, D.-N., Dai, J., Huang, Q., & Tian, L. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.01.018 · Cited by 54
Li, J., Huang, S., Zeng, L., Li, K., Yang, L., Gao, S., Guan, C., Zhang, S., Lao, X., Liao, G., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2538-5 · Cited by 53
Lomphithak, T., Akara-amornthum, P., Murakami, K., Hashimoto, M., Usubuchi, H., Iwabuchi, E., Unno, M., Cai, Z., Sasano, H., & Jitkaew, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-89977-9 · Cited by 53
Liu, L., Huang, L., Chen, W., Zhang, G., Li, Y., Wu, Y., Xiong, J., & Jie, Z. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.811269 · Cited by 52
Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management
Ye, L., Schneider, J. S., Khaled, N. B., Schirmacher, P., Seifert, C., Frey, L., He, Y., Geier, A., Toni, E. N. D., Zhang, C., et al. (2023) · Liver Cancer · doi:10.1159/000530700 · Cited by 55
MYC in liver cancer: mechanisms and targeted therapy opportunities
Liu, F., Liao, Z., & Zhang, Z. (2023) · Oncogene · doi:10.1038/s41388-023-02861-w · Cited by 53
Epigenome Remodeling in Cholangiocarcinoma
O’Rourke, C. J., Lafuente-Barquero, J. F., & Andersen, J. B. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.05.002 · Cited by 48
Shi, S., Verstegen, M. M. A., Mezzanotte, L., de Jonge, J., Löwik, C. W. G. M., & van der Laan, L. J. W. (2019) · Liver Transplantation · doi:10.1002/lt.25488 · Cited by 48
Have incidence rates of liver cancer peaked in the United States?
Petrick, J. L., Florio, A. A., Loomba, R. S., & McGlynn, K. A. (2020) · Cancer · doi:10.1002/cncr.32794 · Cited by 48
The Great Escape: The Power of Cancer Stem Cells to Evade Programmed Cell Death
Castelli, V., Giordano, A., Benedetti, E., Giansanti, F., Quintiliani, M., Cimini, A., & d’Angelo, M. (2021) · Cancers · doi:10.3390/cancers13020328 · Cited by 47
Peng, X., Zhu, J., Liu, S., Luo, C. H., Wu, X., Liu, Z., Li, Y., & Yuan, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.990790 · Cited by 44
Lipid Nanoparticle Delivery of Small Proteins for Potent In Vivo RAS Inhibition
Haley, R. M., Chan, A., Billingsley, M. M., Gong, N., Padilla, M. S., Kim, E. H., Wang, H. H., Yin, D., Wangensteen, K. J., Tsourkas, A., et al. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c01501 · Cited by 43
Xie, J., Tian, W., Tang, Y., Zou, Y., Zheng, S., Wu, L., Zeng, Y., Wu, S., Xie, X., & Xie, X. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.834593 · Cited by 44
Pannexin‐1 limits the production of proinflammatory cytokines during necroptosis
Douanne, T., André‐Grégoire, G., Trillet, K., Thys, A., Papin, A., Feyeux, M., Hulin, P., Chiron, D., Gavard, J., & Bidère, N. (2019) · EMBO Reports · doi:10.15252/embr.201947840 · Cited by 44
Mitochondrial alterations and signatures in hepatocellular carcinoma
Chen, T., Lin, S.-H., Lee, M., Wang, H., Tsai, K., & Chou, C. (2025) · Cancer and Metastasis Reviews · doi:10.1007/s10555-025-10251-9 · Cited by 49
microRNA-199a-3p inhibits hepatic apoptosis and hepatocarcinogenesis by targeting PDCD4
Li, Z., Zhou, Y., Zhang, L., Jia, K., Wang, S., Wang, M., Li, N., Yu, Y., Cao, X., & Hou, J. (2020) · Oncogenesis · doi:10.1038/s41389-020-00282-y · Cited by 45
Metadata
- Authors
- Seehawer, M., Heinzmann, F., D’Artista, L., Harbig, J., Roux, P.-F., Hoenicke, L., Dang, H., Klotz, S., Robinson, L., Doré, G., Rozenblum, N., Kang, T.-W., Chawla, R., Buch, T., Vucur, M., Roth, M., Zuber, J., Luedde, T., Sipos, B., Longerich, T., Heikenwälder, M., Wang, X. W., Bischof, O., & Zender, L.
- Affiliations
- Universitätsklinikum Tübingen (DE)
- Inserm (FR)
- National Cancer Institute (US)
- Institut Pasteur (FR)
- University of Zurich (CH)
- Universitätsklinikum Aachen (DE)
- Research Institute of Molecular Pathology (AT)
- University of Tübingen (DE)
- University Hospital Heidelberg (DE)
- German Cancer Research Center (DE)
- Corresponding author
- Zender, Lars
- ORCID
- Venue
- Nature
- Published
- 2018-09-12
- Volume
- 562
- Issue
- 7725
- Pages
- 69-75
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC8111790
- OpenAlex
- W2890271012
- Cited by
- 406
- References
- 47
- Citations by year
- 2026: 11 · 2025: 43 · 2024: 40 · 2023: 82 · 2022: 83 · 2021: 60 · 2020: 39 · 2019: 43 · 2018: 5
- FWCI
- 23.03
- Type
- journal article
- Language
- en
- Update notices
- correction (2018-11-08)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (Z01BC010313, R01CA136533)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Surgery › Cholangiocarcinoma and Gallbladder Cancer Studies
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Keywords
- necroptosis, tumor microenvironment, lineage commitment, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, hepatocarcinogenesis, epigenetic regulation, TBX3, PRDM5, apoptosis, hepatocyte transformation, cytokine microenvironment
- MeSH terms
- Animals, Cell Differentiation, Disease Models, Animal, DNA Transposable Elements, DNA-Binding Proteins, Female, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Male, Mosaicism, Necrosis, Genes, ras, Transcription Factors, Cytokines, Genes, myc, Apoptosis, Cholangiocarcinoma, Cell Lineage, Cyclin-Dependent Kinase Inhibitor p16, T-Box Domain Proteins, Gene Expression Profiling, Hepatocytes, Epigenesis, Genetic, Proto-Oncogene Proteins c-akt, Mice, Tumor Microenvironment, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
